A biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies, with a primary emphasis on oncology. Its pipeline includes several small‑molecule cancer drugs developed in-house and in partnership with global pharmaceutical companie...
1 member of Congress has disclosed 1 trade in HUTCHMED (China) Ltd (HCM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-05-28 | Rohit Khanna | buy | $1K – $15K |